These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23064529)

  • 1. Intracellular localization of mesothelin predicts patient prognosis of extrahepatic bile duct cancer.
    Kawamata F; Kamachi H; Einama T; Homma S; Tahara M; Miyazaki M; Tanaka S; Kamiyama T; Nishihara H; Taketomi A; Todo S
    Int J Oncol; 2012 Dec; 41(6):2109-18. PubMed ID: 23064529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma.
    Einama T; Kamachi H; Nishihara H; Homma S; Kanno H; Takahashi K; Sasaki A; Tahara M; Okada K; Muraoka S; Kamiyama T; Matsuno Y; Ozaki M; Todo S
    Pancreas; 2011 Nov; 40(8):1276-82. PubMed ID: 21775916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients.
    Hong SM; Kim MJ; Pi DY; Jo D; Cho HJ; Yu E; Ro JY
    Cancer; 2005 Aug; 104(4):802-10. PubMed ID: 15959914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma.
    Yokoyama Y; Hiyama E; Murakami Y; Matsuura Y; Yokoyama T
    Cancer; 1999 Nov; 86(9):1691-9. PubMed ID: 10547541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma.
    Zhou L; He XD; Cui QC; Zhou WX; Qu Q; Zhou RL; Rui JA; Yu JC
    Cancer Lett; 2008 Jun; 264(2):209-17. PubMed ID: 18334282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of fascin expression in extrahepatic bile duct carcinomas.
    Won KY; Kim GY; Lim SJ; Park YK; Kim YW
    Pathol Res Pract; 2009; 205(11):742-8. PubMed ID: 19556073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma.
    Tamada S; Shibahara H; Higashi M; Goto M; Batra SK; Imai K; Yonezawa S
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4257-64. PubMed ID: 16857800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A4 protein and mesothelin expression in dysplasia and carcinoma of the extrahepatic bile duct.
    Zhao H; Davydova L; Mandich D; Cartun RW; Ligato S
    Am J Clin Pathol; 2007 Mar; 127(3):374-9. PubMed ID: 17276942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma with pyloric gland phenotype of the extrahepatic bile ducts: a previously unrecognized and distinctive morphologic variant of extrahepatic bile duct carcinoma.
    Albores-Saavedra J; Chablé-Montero F; Méndez-Sánchez N; Mercado MÁ; Vilatoba-Chapa M; Henson DE
    Hum Pathol; 2012 Dec; 43(12):2292-8. PubMed ID: 22795356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer.
    Kim WB; Han HJ; Lee HJ; Park SS; Song TJ; Kim HK; Suh SO; Kim YC; Choi SY
    Ann Surg Oncol; 2009 Jan; 16(1):23-34. PubMed ID: 18979138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesothelin expression correlates with prolonged patient survival in gastric cancer.
    Baba K; Ishigami S; Arigami T; Uenosono Y; Okumura H; Matsumoto M; Kurahara H; Uchikado Y; Kita Y; Kijima Y; Kitazono M; Shinchi H; Ueno S; Natsugoe S
    J Surg Oncol; 2012 Feb; 105(2):195-9. PubMed ID: 21780126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of retinoblastoma protein and p16INK4 protein expression in extrahepatic bile duct carcinomas.
    Cui X; Hui AM; Li X; Shi YZ; Takayama T; Hatakeyama K; Makuuchi M
    Hepatogastroenterology; 2000; 47(35):1216-20. PubMed ID: 11100316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.
    Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T
    Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
    Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
    Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of CD10 in benign and malignant extrahepatic bile duct lesions.
    Tretiakova M; Antic T; Westerhoff M; Mueller J; Himmelfarb EA; Wang HL; Xiao SY
    Am J Surg Pathol; 2012 Jan; 36(1):101-8. PubMed ID: 21989348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
    Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
    Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.
    Jung G; Park KM; Lee SS; Yu E; Hong SM; Kim J
    J Hepatol; 2012 Oct; 57(4):787-93. PubMed ID: 22634127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
    Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M
    Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer.
    Einama T; Homma S; Kamachi H; Kawamata F; Takahashi K; Takahashi N; Taniguchi M; Kamiyama T; Furukawa H; Matsuno Y; Tanaka S; Nishihara H; Taketomi A; Todo S
    Br J Cancer; 2012 Jun; 107(1):137-42. PubMed ID: 22644300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of basement membrane type IV collagen α2 and α6 chains as a prognostic factor in patients with extrahepatic bile duct carcinoma.
    Hirashima K; Iyama K; Baba Y; Honda Y; Sado Y; Ninomiya Y; Watanabe M; Takamori H; Beppu T; Baba H
    J Surg Oncol; 2013 Mar; 107(4):402-7. PubMed ID: 22927259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.